Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02984943 · ClinicalTrials.gov registry record · NA
The Effects of Hyperbaric Oxygen on Rheumatoid Arthritis
A NA study, sponsored by David Grant U.S. Air Force Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT02984943 is a NA study that has completed, run by David Grant U.S. Air Force Medical Center. The registered enrollment target is 14 participants.
The verdict
NCT02984943, a NA study, has completed, sponsored by David Grant U.S. Air Force Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The purpose of this investigation is to determine the effects and ease of using hyperbaric oxygen therapy HBO2 for the treatment of rheumatoid arthritis joint pain and prevention of disease progression. In this study it is our intention to not only evaluate effects and ease of treatment but time, cost, possible adverse events and effect size in an attempt to predict an appropriate sample size and improve on the study design prior to a more extensive study.
Interventions
- DEVICE Hyperbaric Oxygen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2017-01-19 |
| Est. Completion | 2019-04-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02984943
The ClinicalTrials.gov registry entry for NCT02984943 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is David Grant U.S. Air Force Medical Center, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hyperbaric Oxygen is the first listed.
NCT02984943 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02984943 about?
NCT02984943 is a clinical study titled "The Effects of Hyperbaric Oxygen on Rheumatoid Arthritis". The purpose of this investigation is to determine the effects and ease of using hyperbaric oxygen therapy HBO2 for the treatment of rheumatoid arthritis joint pain and prevention of disease progression. In this study it is our intention to not only evaluate effects and ease of treatment but time, co...
What is the current status of trial NCT02984943?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2017-01-19. Estimated completion is 2019-04-10.
What interventions are being tested in trial NCT02984943?
The interventions under investigation include: Hyperbaric Oxygen (DEVICE).
Who is sponsoring clinical trial NCT02984943?
This trial is sponsored by David Grant U.S. Air Force Medical Center, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.